GlassScriptPhysician profile
Ali Kaabi
NPI 1487217261
$918.50
in general payments reported to CMS, 2019-2025
9 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $117 · 2023: $98.67 · 2024: $491 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $174.50 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Abbvie INC. | $151.95 | 2024-2025 | |
| Penumbra, INC. | $134.82 | 2024 | Red 72 |
| Novo Nordisk INC | $116.55 | 2022 | |
| Biogen, INC. | $98.67 | 2023 | Tysabri |
| Neurelis, INC. | $97.71 | 2024-2025 | Valtoco |
| Ucb, INC. | $72.02 | 2024-2025 | Briviact, Fintepla |
| Lundbeck LLC | $48.47 | 2024-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $23.81 | 2025 | Kisunla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Kaabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.